In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio

Author:

Baabur-Cohen Hemda,Vossen Laura Isabel,Krüger Harald Rune,Eldar-boock Anat,Yeini Eilam,Landa-Rouben Natalie,Tiram Galia,Wedepohl Stefanie,Markovsky Ela,Leor Jonathan,Calderón Marcelo,Satchi-Fainaro Ronit

Funder

European Research Council (ERC)

Israel Science Foundation

Israeli National Nanotechnology Initiative (INNI)

Focal Technology Area (FTA) program: Nanomedicine for Personalized Theranostics

Leona M. and Harry B. Helmsley Nanotechnology Research Fund

Focus Area Nanoscale

Bundesministerium für Bildung und Forschung (BMBF)

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging;Glasgow;J. Biomed. Nanotechnol.,2015

2. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs;Matsumura;Cancer Res.,1986

3. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer;Willett;Nat. Med.,2004

4. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?;Kobayashi;Theranostics,2014

5. Importance of molecular architecture;Fox;Acc. Chem. Res.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3